the differences between mcrpc and nmcrpc
Published 5 years ago • 615 plays • Length 2:50Download video MP4
Download video MP3
Similar videos
-
4:56
improving the prognosis for patients with mcrpc
-
1:46
os after progression on first novel hormonal therapy in mcspc vs mcrpc
-
3:38
the nccn and aua guidelines for treating nmcrpc
-
3:06
the best therapy option for a patient with mcrpc
-
8:21
ep. 10: how has the mcrpc treatment landscape changed?
-
1:22
cabazitaxel improves rpfs in patients with mcrpc
-
16:39
metastatic castration resistant prostate cancer (mcrpc) – inroads in improved outcomes
-
7:52
case 3: treatment after progression to mcrpc
-
45:15
treatment updates for advanced prostate cancer – 2023 zero prostate cancer summit
-
55:29
urowebinar: metastatic prostate cancer
-
34:00
jnm podcast episode 4: the standard of care for metastatic prostate cancer
-
1:01
evaluating tumor-directed pet imaging of mcrpc bone metastases using zr-89-j591
-
9:00
differences between ar-targeted therapy in prostate cancer
-
5:57
managing bone metastasis in patients with mcrpc
-
3:09
mcrpc: sequencing therapy
-
2:49
overall survival data in mcrpc
-
0:34
discussing the safety profile of cabazitaxel in mcrpc
-
5:10
mcspc: treatment after progression on ar-targeted therapy
-
5:47
bone versus visceral metastases in mcrpc
-
3:51
impressions of a patient with progression to mcrpc
-
3:47
case 3: factors to consider in mcrpc treatment
-
1:38
nmcrpc: therapy evolution and future